Erratum: Clinical Outcomes in Patients Receiving Originator Follitropin Alfa and Follitropin Alfa Biosimilars in Real-world Clinical Practice: A Retrospective Study

Erratum: Clinical Outcomes in Patients Receiving Originator Follitropin Alfa and Follitropin Alfa Biosimilars in Real-world Clinical Practice: A Retrospective Study

Saved in:

Bibliographic Details
Format:	Article
Language:	English
Published:	Wolters Kluwer Medknow Publications 2023-07-01
Series:	Journal of Human Reproductive Sciences
Online Access:	https://journals.lww.com/10.4103/0974-1208.386502
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Clinical Outcomes in Patients Receiving Originator Follitropin Alfa and Follitropin Alfa Biosimilars in Real-world Clinical Practice: A Retrospective Study
by: Nayana Hitesh Patel, et al.
Published: (2023-04-01)

Corrigendum: Cipaglucosidase alfa plus miglustat: linking mechanism of action to clinical outcomes in late-onset Pompe disease
by: Barry J. Byrne, et al.
Published: (2025-01-01)

Experimental investigation of the mechanical properties of Alfas stone
by: Konstas N. Kaklis, et al.
Published: (2017-04-01)

Experimental investigation of the mechanical properties of Alfas stone
by: Kostas N. Kaklis, et al.
Published: (2017-04-01)

Epoetin-alfa-induced osteogenesis in the bone organoid model
by: Natalia A. Nadezhdina, et al.
Published: (2024-12-01)

Andexanet alfa: trials just leave us with more questions
by: Richard J. Buka
Published: (2025-01-01)

Budget Impact Analysis of Darbepoetin Alfa Every 3 Weeks versus Epoetin Alfa Every Week for Cancer Patients with Anemia due to the Effect of Concomitant Myelosuppressive Chemotherapy
by: November McGarvey, et al.
Published: (2015-11-01)

Alfa-Fetoprotein-Producing Female Primary Urethral Adenocarcinoma with Neuroendocrine Differentiation
by: Takao Natsuyama, et al.
Published: (2019-01-01)

Biosimilars in Focus: Evaluating Their Role Compared to Adalimumab in Clinical Practice
by: Dorota Waz, et al.
Published: (2025-01-01)

Pokolenie Alfa w szkole. Działania projektowo-wdrożeniowe z wykorzystaniem ICT
by: Eunika Baron-Polańczyk, et al.
Published: (2022-12-01)

Additive Effect of Dornase Alfa and Nacystelyn on Transportability and Viscoelasticity of Cystic Fibrosis Sputum
by: Feng Sun, et al.
Published: (2002-01-01)

QSAR modelling and docking analysis of some thiazole analogues as alfa-glucosidase inhibitors
by: Muhammad Tukur Ibrahim, et al.
Published: (2019-06-01)

The Use of Exogenous Lung Surfactant (Poractant Alfa) in Acute Respiratory Failure by Drowning
by: Mario Pezzi, et al.
Published: (2020-01-01)

Altered Thyroid Function Tests Observed in Hypophosphatasia Patients Treated with Asfotase Alfa
by: Hajime Kato, et al.
Published: (2021-01-01)

Experimental and Numerical Analyses of Alfa/Polyester Composite Under Three-Point Bending
by: Mokhtar Belkacem, et al.
Published: (2025-04-01)

Implementation of Internasional-Based Curriculum Alfa and Friends to Development Early Childhood Language
by: Ika Nurul Amalia, et al.
Published: (2024-12-01)

Real-World Assessment of Clinical Outcomes in Patients with Lower-Risk Myelofibrosis Receiving Treatment with Ruxolitinib
by: Keith L. Davis, et al.
Published: (2015-01-01)

Phase I study of efineptakin alfa (NT-I7) for the treatment of Kaposi sarcoma
by: Leonard D’Amico, et al.
Published: (2025-02-01)

ALFA e BETO: como avaliar leitura e escrita na Educação Infantil?
by: Magna do Carmo Silva, et al.
Published: (2020-05-01)

Subcutaneous Sarcoidosis during Pegylated Interferon Alfa and Ribavirin Treatment for Chronic Hepatitis C
by: R. Rodríguez-Lojo, et al.
Published: (2010-01-01)

Efficacy of pegylated interferon alfa-2b «Algeron» in the treatment of chronic hepatitis C
by: M. V. Mayevskaya, et al.
Published: (2013-03-01)

De alfa a omega: Estimación de la confiabilidad ordinal. Una guía práctica
by: Nicolás Vizioli, et al.
Published: (2022-12-01)

Effects of MAPP Compatibilization and Acetylation Treatment Followed by Hydrothermal Aging on Polypropylene Alfa Fiber Composites
by: Noura Hamour, et al.
Published: (2015-01-01)

Andexanet alfa for oral fxa inhibitor-associated major acute intracerebral hemorrhage: insights into clinically relevant thromboembolic events from the ANNEXA-I study
by: Mateo Porres-Aguilar, et al.
Published: (2025-01-01)

Real-World Evidence of Clinical Outcomes of the Use of the Adalimumab Biosimilar SB5 in Rheumatic and Gastrointestinal Immune-Mediated Inflammatory Diseases: 12-Month Data from the PERFUSE Study
by: Bruno Fautrel, et al.
Published: (2024-10-01)

Ductus Venosus Doppler S/D Value Adjusted Alfa Fetoprotein Levels to Decrease False Positive Rates
by: Alptekin Tosun, et al.
Published: (2013-12-01)

CURRENT APPROACH TO DEVELOPMENT OF BIOSIMILAR PRODUCTS CONTAINING MONOCLONAL ANTIBODIES AS AN ACTIVE SUBSTANCE – NON-CLINICAL AND CLINICAL STUDIES OF THE FIRST RUSSIAN RITUXIMAB BIOSIMILAR, ACELLBIA®
by: S. M. Alekseev, et al.
Published: (2015-04-01)

¿Por qué es importante reportar los intervalos de confianza del coeficiente alfa de Cronbach?
by: Sergio Alexis Domínguez-Lara, et al.
Published: (2015-01-01)

Lichen Planus Induced by Pegylated Interferon Alfa-2a Therapy in a Patient Monitored for Delta Hepatitis
by: Safak Kaya, et al.
Published: (2015-01-01)

Characterization of IXINITY® (Trenonacog Alfa), a Recombinant Factor IX with Primary Sequence Corresponding to the Threonine-148 Polymorph
by: Dougald M. Monroe, et al.
Published: (2016-01-01)

Case Report: Two years of compassionate use with Olipudase-alfa in a child with neurovisceral acid sphingomyelinase deficiency
by: Federica Deodato, et al.
Published: (2025-01-01)

Assessing the effectiveness of the SOLIO Alfa Cure Plus device in treating low back pain: a randomized controlled study
by: Hadari Yotam, et al.
Published: (2025-01-01)

IS IT POSSIBLE TO USE BEVACIZUMAB BIOSIMILAR IN ALL INDICATIONS REGISTERED FOR ORIGINAL DRUG?
by: S. V. Orlov, et al.
Published: (2016-06-01)

Hubungan Tumor Necrosis Factor-Alfa (Tnf-A) dengan Kadar Hemoglobin dan Parasitemia pada Infeksi Malaria Falciparum
by: Lili Irawati
Published: (2014-05-01)

DETERMINACIÓN DE LAS PROPIEDADES DE LA ENZIMA ALFA AMILASA PARA SU USO EN LA INDUSTRIA AZUCARERA
by: Saul Dueñas Casas, et al.
Published: (2024-12-01)

The “Brave New World” of biosimilars: Look before you leap!
by: Lathika Vasu Kamaladevi
Published: (2024-12-01)

Clinical Outcomes and Patient Experience of Biosimilar to Biosimilar Infliximab Switching in Patients with Inflammatory Bowel Disease: A Prospective, Single-Centre, Phase IV Interventional Study with a Nested Qualitative Study
by: Clare Harris, et al.
Published: (2023-01-01)

Clinical Outcomes from Unselected “Real-World” Patients with Long Coronary Lesion Receiving 40 mm Biodegradable Polymer Coated Sirolimus-Eluting Stent
by: Anurag Polavarapu, et al.
Published: (2015-01-01)

Efecto del ácido alfa lipoico sobre la peroxidación no enzimática en mitocondrias de corazón y cerebro de rata
by: M. Marmunti, et al.
Published: (2021-01-01)

Pre-failure indicators detected by Acoustic Emission: Alfas stone, cement-mortar and cement-paste specimens under 3-point bending
by: Stavros K. Kourkoulis, et al.
Published: (2017-04-01)